Publications by authors named "Graham Maw"

Claim this Profile
D
Discovery and Optimization of Selective Nav1.8 Modulator Series That Demonstrate Efficacy in Preclinical Models of Pain.
Sharan K Bagal, Peter J Bungay, Stephen M Denton, Karl R Gibson, Melanie S Glossop, Graham N Maw

ACS Med Chem Lett· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Selective TRPM8 Antagonist with Clinical Efficacy in Cold-Related Pain.
Mark D Andrews, Kerry Af Forselles, Kevin Beaumont, Sébastien R G Galan, Paul A Glossop, Graham Maw

ACS Med Chem Lett· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of UK-369003, a novel PDE5 inhibitor with the potential for oral bioavailability and dose-proportional pharmacokinetics.
David J Rawson, Stephen Ballard, Christopher Barber, Laura Barker, Kevin Beaumont, Graham Maw

Bioorg Med Chem· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Part 3: Design and synthesis of proline-derived α2δ ligands.
David J Rawson, Delphine Brugier, Anthony Harrison, Jo Hough, Julie Newman, Graham N Maw

Bioorg Med Chem Lett· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Part 2: Design, synthesis and evaluation of hydroxyproline-derived α2δ ligands.
David J Rawson, Delphine Brugier, Anthony Harrison, Jo Hough, Julie Newman, Graham N Maw

Bioorg Med Chem Lett· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Part 1: N-alkylated glycines as potent α2δ ligands.
Lisa R Thompson, David C Blakemore, Delphine Brugier, Justin S Bryans, Wai-Lam A Chu, Graham N Maw

Bioorg Med Chem Lett· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SAR of a series of inhaled A(2A) agonists and comparison of inhaled pharmacokinetics in a preclinical model with clinical pharmacokinetic data.
Simon J Mantell, Peter T Stephenson, Sandra M Monaghan, Graham N Maw, Michael A Trevethick

Bioorg Med Chem Lett· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo SAR of pyrido[3,4-d]pyramid-4-ylamine based mGluR1 antagonists.
Simon J Mantell, Karl R Gibson, Simon A Osborne, Graham N Maw, Huw Rees

Bioorg Med Chem Lett· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2,4-Diaminopyridine delta-opioid receptor agonists and their associated hERG pharmacology.
Dafydd R Owen, Margarita Rodriguez-Lens, Martin D Corless, Steven M Gaulier, Valerie A Horne, Graham N Maw

Bioorg Med Chem Lett· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhaled adenosine A(2A) receptor agonists for the treatment of chronic obstructive pulmonary disease.
Simon J Mantell, Peter T Stephenson, Sandra M Monaghan, Graham N Maw, Michael A Trevethick

Bioorg Med Chem Lett· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel, efficient, diastereo- and enantioselective Mukaiyama aldol-based synthesis of a vinyl cyclopentanone core derivative of viridenomycin.
Andrei S Batsanov, Jonathan P Knowles, Andrew P Lightfoot, Graham Maw, Carl E Thirsk

Org Lett· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships of novel non-competitive mGluR1 antagonists: a potential treatment for chronic pain.
Dafydd R Owen, Peter G Dodd, Simon Gayton, Ben S Greener, Gareth W Harbottle, Graham N Maw

Bioorg Med Chem Lett· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small molecule inhibitors of IgE synthesis.
Alan Brown, Alan Henderson, Charlotte Lane, Mark Lansdell, Graham Maw

Bioorg Med Chem Lett· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel selective inhibitors of neutral endopeptidase for the treatment of female sexual arousal disorder. Synthesis and activity of functionalized glutaramides.
David C Pryde, Graham N Maw, Simon Planken, Michelle Y Platts, Vivienne Sanderson

J Med Chem· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel series of potent and selective PDE5 inhibitors with potential for high and dose-independent oral bioavailability.
Charlotte M N Allerton, Christopher G Barber, Kevin C Beaumont, David G Brown, Susan M Cole, Graham N Maw

J Med Chem· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly potent and selective zwitterionic agonists of the delta-opioid receptor. Part 1.
Donald S Middleton, Graham N Maw, Clare Challenger, Alan Jessiman, Patrick S Johnson

Bioorg Med Chem Lett· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of small molecule inhibitors of neutral endopeptidase. Structure-activity studies on functionalized glutaramides.
Graham N Maw, Alan Stobie, Simon Planken, David C Pryde, Vivienne Sanderson

Chem Biol Drug Des· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and biological activity of beta-carboline-based type-5 phosphodiesterase inhibitors.
Graham N Maw, Charlotte M N Allerton, Eugene Gbekor, William A Million

Bioorg Med Chem Lett· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis